Osaic Holdings’s Acadia Pharmaceuticals ACAD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $86.1K | Sell |
4,360
-4,699
| -52% | -$92.8K | ﹤0.01% | 4287 |
|
|
2025
Q1 | $150K | Buy |
9,059
+2,914
| +47% | +$48.4K | ﹤0.01% | 3860 |
|
|
2024
Q4 | $106K | Sell |
6,145
-759
| -11% | -$13.1K | ﹤0.01% | 4117 |
|
|
2024
Q3 | $106K | Buy |
6,904
+696
| +11% | +$10.7K | ﹤0.01% | 4169 |
|
|
2024
Q2 | $100K | Sell |
6,208
-2,615
| -30% | -$42.3K | ﹤0.01% | 4131 |
|
|
2024
Q1 | $162K | Sell |
8,823
-20,341
| -70% | -$374K | ﹤0.01% | 3869 |
|
|
2023
Q4 | $913K | Sell |
29,164
-71,142
| -71% | -$2.23M | ﹤0.01% | 2605 |
|
|
2023
Q3 | $2.09M | Buy |
100,306
+68,397
| +214% | +$1.43M | ﹤0.01% | 1949 |
|
|
2023
Q2 | $767K | Buy |
31,909
+7,234
| +29% | +$174K | ﹤0.01% | 2758 |
|
|
2023
Q1 | $461K | Buy |
24,675
+2,689
| +12% | +$50.3K | ﹤0.01% | 3165 |
|
|
2022
Q4 | $350K | Sell |
21,986
-998
| -4% | -$15.9K | ﹤0.01% | 3375 |
|
|
2022
Q3 | $377K | Buy |
22,984
+109
| +0.5% | +$1.79K | ﹤0.01% | 3164 |
|
|
2022
Q2 | $322K | Sell |
22,875
-800
| -3% | -$11.3K | ﹤0.01% | 3359 |
|
|
2022
Q1 | $482K | Sell |
23,675
-2,810
| -11% | -$57.2K | ﹤0.01% | 3254 |
|
|
2021
Q4 | $623K | Buy |
26,485
+2,399
| +10% | +$56.4K | ﹤0.01% | 2853 |
|
|
2021
Q3 | $403K | Sell |
24,086
-1,593
| -6% | -$26.7K | ﹤0.01% | 3258 |
|
|
2021
Q2 | $630K | Sell |
25,679
-1,267
| -5% | -$31.1K | ﹤0.01% | 2771 |
|
|
2021
Q1 | $697K | Sell |
26,946
-2,806
| -9% | -$72.6K | ﹤0.01% | 2541 |
|
|
2020
Q4 | $1.59M | Sell |
29,752
-1,216
| -4% | -$64.9K | ﹤0.01% | 1636 |
|
|
2020
Q3 | $1.32M | Buy |
30,968
+6,593
| +27% | +$281K | ﹤0.01% | 1621 |
|
|
2020
Q2 | $1.18M | Buy |
24,375
+545
| +2% | +$26.4K | ﹤0.01% | 1635 |
|
|
2020
Q1 | $1.01M | Buy |
+23,830
| New | +$1.01M | ﹤0.01% | 1530 |
|